Rhodiola algida improves chemotherapy-induced oral mucositis in breast cancer patients

Expert Opinion on Investigational Drugs

Volumn 19, Issue SUPPL. 1, 2010, Pages

  Loo, Wings T Y ^a,b,c   Jin, Lj ^c   Chow, Louis W C ^a,b,d,e   Cheung, Mary N B ^a   Wang, Min ^d  

^a UNIMED Medical Institute   (Hong Kong)

^b Organisation for Oncology and Translational Research   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e SICHUAN UNIVERSITY   (China)

Author keywords

Colony formation; Cytokines; Immune system; Oral ulcer Rhodiola algida; T lymphocyte transformation

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; CHLORHEXIDINE; CYCLOPHOSPHAMIDE; CYTOKINE; EPIRUBICIN; FLUOROURACIL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; PLANT EXTRACT; RHODIOLA ALGIDA EXTRACT; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD CELL COUNT; BREAST CANCER; CANCER PATIENT; CELL ASSAY; CELL ISOLATION; CELL PROLIFERATION; CHEMOTHERAPY INDUCED EMESIS; CHINESE MEDICINE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG EFFICACY; FEEDING; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRADUCTAL CARCINOMA; KIDNEY DISEASE; KIDNEY FUNCTION TEST; LABORATORY TEST; LEUKOCYTE COUNT; LIVER DISEASE; LIVER FUNCTION TEST; LYMPHOCYTE; MAJOR CLINICAL STUDY; MASTECTOMY; MOUTH ULCER; MULTIPLE CYCLE TREATMENT; NAUSEA; NONHUMAN; PAIN; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT REDUCTION; WOUND HEALING;

ADULT; ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOKINES; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; PILOT PROJECTS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RHODIOLA; RNA, MESSENGER; STOMATITIS; YOUNG ADULT;

EID: 77950631233     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543781003727057     Document Type: Conference Paper

References (55)

1. Darbinyan V, Kteyan A, Panossian A, et al. Rhodiola rosea in stress induced fatigue-a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine 2000;7:365-371
2. Shevtsov VA, Zholus BI, Shervarly VI, et al. A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine 2003;10:95-105
3. Spasov AA, Wikman GK, Mandrikov VB, et al. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regime. Phytomedicine 2000;7:85-89
4. Abidov M, Crendal F, Grachev S, et al. Effect of extracts from Rhodiola rosea and Rhodiola crenulata (Crassulaceae) roots on ATP content in mitochondria of skeletal muscles. Bull Exp Biol Med 2003;136:585-587
5. Abidov M, Grachev S, Seifulla RD, et al. Extract of Rhodiola rosea radix reduces the level of C-reactive protein and creatinine kinase in the blood. Bull Exp Biol Med 2004;138:63-64
6. Bocharova OA, Matveev BP, Baryshnikov AIU, et al. The effect of a Rhodiola rosea extract on the incidence of recurrences of a superficial bladder cancer (experimental clinical research). Urol Nefrol (Mosk) 1995;2:46-47
7. Colonna M. Can we apply the TH1-TH2 paradigm to all lymphocytes? Nat Immunol 2001;2:899-900
8. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003;8:223-246
9. Romagnani S, Kapsenberg M, Radbruch A, et al. Th1 and Th2 cells. Res Immunol 1998;149:871-873
10. Joost J. In: Ruscetti FW, editor, Oppenheim, medical immunology: cytokines. McGraw-Hill Companies, Inc.; 2001. p. 148-166
11. Tadamitsu Kishimoto. Interleukins: molecular biology and immunology. Karger, Basel, Switzerland; 1992. p. P5-280
12. Pulendran B, Smith JL, Caspary G, et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci USA 1999;96:1036-1041
13. Cates EC, Gajewska BU, Goncharova S, et al. Effect of GM-CSF on immune, inflammatory, and clinical responses to ragweed in a novel mouse model of mucosal sensitization. J Allergy Clin Immunol 2003;111:1076-1086
14. Woodside KJ, Hu M, Gugliuzza KK, et al. T-lymphocyte apoptosis is increased by non-interleukin-2-dependent induction in human mixed lymphocyte cultures. Transplant Proc 2005;37:1949-1952
15. van der Wall E, Rutgers EJ, Holtkamp MJ, et al. Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients. Br J Cancer 1996;73:1080-1085
16. Poole CJ, Earl HM, Hiller L, et al. Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer. N Engl J Med 2006;355:1851-1862
17. Fornier M, Norton L. Dose-dense adjuvant chemotherapy for primary breast cancer. Breast Cancer Res 2005;7:64-69 (Pubitemid 40352672)
18. Grieve RJ. Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer. N Engl J Med 2006;55:1851-1862
19. Chauhan A, Singh H, Sharma T, et al. Gemcitabine concurrent with radiation therapy for locally advanced head and neck carcinomas. Afr Health Sci 2008;8:149-155
20. Kostler WJ, Hejna M, Wenzel C, et al. Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment. CA Cancer J Clin 2001;51:290-315
21. Sonis ST, Sonis AL, Lieberman A. Oral complications in patients receiving treatment for malignancies other than head and neck. J Am Dent Assoc 1978;97:468-472
22. Dreizen S, McCredie KB, Keating MJ. Chemotherapy induced mucositis in adult leukemia. Postgrad Med 1981;69:10.V108
23. Sonis S, Clark J. Prevention and management of oral mucositis induced by antineoplastic therapy. Oncology 1991;5:6-10
24. Chow LW, Loo WT, Sham JS. Effects of a herbal compound containing bupleurum on human lymphocytes. Hong Kong Med J 2001;7:408-413
25. Yraola F, Garćia-Vicente S, Fernandez-Recio J, et al. New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking. J Med Chem 2006;49:6197-6208
26. Tolonen A, Pakinen M, Hohtola A, et al. Phenylpropanoid glycoside from Rhodiola rosea. Chem Pharm Bull 2003;51:467-470
27. Janni W, Rjosk D, Strobl B, et al. Chemotherapy-associated myelosuppression in gynecological oncology. Gynakol Geburtshilfliche Rundsch 2001;41:166-173
28. Mills GB, Lee JWW, Cheung RK, et al. Characterization of the requirements for human T cell mitogenesis by using suboptimal concentrations of phytohemagglutinin. J Immunol 1985;135:3087-3093
29. Suvachittanont W, Jaranchavanapet P. Mitogenic effect of Parkia speciosa seed lectin on human lymphocytes. Planta Med 2000;66:699-704
30. Zhao H, Jia LY, Sun CS. Determination of the content of salidroside in the compound tablets of Rhodila by RP-HPLC. J Sheng Pharm Univ 2005;22:23-25
31. Chakravorty SJ, Howie AJ, Cockwell P, et al. T lymphocyte adhesion mechanisms within inflamed human kidney: studies with a Stamper-Woodruff assay. Am J Pathol 1999;154:503-514
32. Sakkas LI, Scanzello C, Johanson N, et al. T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis. Clin Diagn Lab Immunol 1998;5:430-437
33. Nash MA, Lenzi R, Edwards CL, et al. Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines. Clin Exp Immunol 1998;112:172-180
34. Khouri VY, Stracieri AB, Rodrigues MC, et al. Use of therapeutic laser for prevention and treatment of oral mucositis. Braz Dent J 2009;20(3):215-220
35. McCaffery M, Beebe A. Pain: clinical manual for nursing practice. Baltimore: V.V. Mosby Company; 1989. p. 25-95
36. Lange BJ. Growth of human leukemia cells in vitro. In: Baserga R, editor, Cell growth and division: a practical approach. Oxford: Oxford University Press; 1989. p. 61-80
37. Furmanowa M, Skopinska-Rozewska E, Rogala E, et al. Rhodiola rosea in vitro culture-phytochemical analysis and antioxidant action. Acta Soc Bot Pol 1998;67:69
38. Sokolov S, Ivashin VM, Zapesochnaya G. Studies of neurotropic activity of new compounds isolated from Rhodiola rosea. Khim Farm Zh 1985;19:1367
39. Ming HQ, Xia GC, Zhang RD. Advanced research on Rhodiola sachalinensis. Chin Tradit Herb Drugs 1988;19:229-234
40. Kang S, Wang J, Zhang J. Quantitative analysis of salidroside and lotaustralin in Rhodiola by gas chromatography. Zhongguo Zhong Yao Za Zhi 1998;23:365-366
41. An F, Yue S, Guo D, et al. Determination of salidroside in eight Rhodiola species by TLC-UV spectrometry. Zhongguo Zhong Yao Za Zhi 1998;23:43-44
42. Linh PT, Kim YH, Hong SP, et al. Quantitative determination of salidroside and tyrosol from the underground part of Rhodiola rosea by high performance liquid chromatography. Arch Pharm Res 2000;23:349-352
43. Starkie RL, Rolland J, Febbraio MA. Effect of adrenergic blockade on lymphocyte cytokine production at rest and during exercise. Am J Physiol Cell Physiol 2001;281:1233-1240
44. Suzuki K, Nakaji S, Yamada M, et al. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exerc Immunol Rev 2002;8:6-48
45. Zlotnik A, Ransom J, Frank G, et al. Interleukin 4 is a growth factor for activated thymocytes: possible role in T-cell ontogeny. Proc Natl Acad Sci USA 1987;84:3856-3860
46. Spits H, Yssel H, Paliard X, et al. IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed lymphocyte culture. J Immunol 1988;141:29-36
47. Kawakami Y, Rosenberg SA, Lotze MT. Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma. J Exp Med 1988;168:85-94
48. Stanley E, Lieschke GJ, Grail D, et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 1994;91:5592-5596
49. Wada H, Noguchi Y, Marino MW, et al. T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice. Proc Natl Acad Sci USA 1997;94:12557-12561
50. Gonzalez-Juarrero M, Hattle JM, Izzo A, et al. Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection. J Leukoc Biol 2005;77:914-922
51. Stämpfli MR, Wiley RE, Neigh GS, et al. GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice. J Clin Invest 1998;102:1704-1714
52. Barouch DH, Santra S, Tenner-Racz K, et al. Potent CD4 + T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF. J Immunol 2002;168:562-568
53. Kim JJ, Ayyavoo V, Bagarazzi ML, et al. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J Immunol 1997;158:816-826
54. Wong CK, Bao YX, Wong EL, et al. Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients. Am J Chin Med 2005;33:381-395
55. Hakonarson H, Maskeri N, Carter C, et al. Regulation of TH1-and TH2-type cytokine expression and action in atopic asthmatic sensitized airway smooth muscle. J Clin Invest 1999;103:1077-1087